title: Indication for increasing prevalence of resistance mutations for protease inhibitors in therapy-naive HIV-1-positive German patients.
authors.forename: U
authors.initials: U
authors.lastname: Dietrich
authors.forename: I
authors.initials: I
authors.lastname: Raudonat
authors.forename: E
authors.initials: E
authors.lastname: Wolf
authors.forename: H
authors.initials: H
authors.lastname: Jäger
authors.forename: R
authors.initials: R
authors.lastname: Husak
authors.forename: C E
authors.initials: CE
authors.lastname: Orfanos
authors.forename: M
authors.initials: M
authors.lastname: Knickmann
authors.forename: H
authors.initials: H
authors.lastname: Knechten
authors.forename: H
authors.initials: H
authors.lastname: von Briesen
authors.forename: H
authors.initials: H
authors.lastname: Ruppach
authors.forename: A
authors.initials: A
authors.lastname: Immelmann
mesh_terms: D019380:Anti-HIV Agents / Q000494:pharmacology / Q000627:therapeutic use; D004352:Drug Resistance, Microbial / Q000235:genetics; D005858:Germany; D015658:HIV Infections / Q000188:drug therapy* / Q000208:ethnology / Q000821:virology*; D017320:HIV Protease Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D015497:HIV-1 / Q000187:drug effects* / Q000235:genetics; D006801:Humans; D009154:Mutation
chemical_list: D019380:Anti-HIV Agents; D017320:HIV Protease Inhibitors